← All trials
NCT00478647
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2007
- Primary completion
- Jul 1, 2009
- Completion date
- Aug 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- ShireLead sponsor
- New York UniversityOverall official - principal investigator
- Northwestern UniversityOverall official - principal investigator
- Baylor UniversityOverall official - principal investigator
- University of California, San FranciscoOverall official - principal investigator
- University of WisconsinOverall official - principal investigator
- University of CincinnatiOverall official - principal investigator
- University of ZaragozaOverall official - principal investigator
- ShireStudy director
- University of LondonOverall official - principal investigator
- ShireCollaborator
- Emory UniversityOverall official - principal investigator
- Hebrew UniversityOverall official - principal investigator
- Children's Memorial Health Institute, PolandOverall official - principal investigator
- University of KansasOverall official - principal investigator
- University of MinnesotaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.